Targeted treatment strategy for patients with severe pulmonary hypertension secondary to connective tissue diseases
Abstract Background Pulmonary arterial hypertension (PAH) associated with connective tissue diseases (CTD) (CTD‐PAH) remains a difficult challenge in clinical practice. We aimed to evaluate the effects of targeted vasodilators in patients with severe CTD‐PAH. Methods The data of 53 patients with sev...
Main Authors: | Bo Jiang, Chun Wang, Yansheng Jin, Guanjun Guo, Kangxing Zhou, Xuebing Feng, Genhong Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-09-01
|
Series: | Rheumatology & Autoimmunity |
Subjects: | |
Online Access: | https://doi.org/10.1002/rai2.12086 |
Similar Items
-
Connective tissue disease‐associated pulmonary hypertension: A comprehensive review
by: Vikramjit Khangoora, et al.
Published: (2023-10-01) -
Recent developments in connective tissue disease associated pulmonary arterial hypertension
by: Stefano Rodolfi, et al.
Published: (2024-06-01) -
Cardiac Catheterization versus Echocardiography for Monitoring Pulmonary Pressure: A Prospective Study in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
by: Vasiliki Kalliopi Bournia, et al.
Published: (2020-01-01) -
Recent Advances in the Treatment of Pulmonary Arterial Hypertension
by: Naoyuki Otani, et al.
Published: (2022-10-01) -
Association of red cell distribution width with pulmonary arterial hypertension in patients with mixed connective tissue disease
by: Yansheng Jin, et al.
Published: (2023-08-01)